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Background: The objective of the present study was to determine the prevalence of coronary
artery disease (CAD) in patients undergoing surgery for various valvular as well as non-
valvular cardiac pathologies.
Methods: Patients with various valvular and non-valvular pathologies were selected. All
patients with age 40 years and an indication for open heart surgery underwent pre-
operative coronary angiogram and were included in the study.
Results: The mean age was 51.5  9.02 years. 178 (59.3%) patients were males and 122
(40.7%) patients were females. Out of 300 patients, 270 (90%) patients had valvular heart
disease (VHD) and 30 (10%) patients had non-valvular heart disease. Rheumatic heart
disease (RHD), mitral valve prolapse (MVP), degenerative aortic valve disease (DAVD) and
bicuspid aortic valve (BAV) was present in 161 (53.7%), 17 (5.7%), 60 (20%) and 32 (10.7%)
patients respectively. Overall, 26 (8.7%) patients were found to have significant CAD. CAD
was significantly more common in patients with VHD as compared to patients with other
etiologies (1 patient, 3.3%, p < 0.05). In the valvular group, DAVD patients had maximum
prevalence of CAD (14 patients, 23.4%, p < 0.05). In the group with CAD, the presence of
variables such as age >60 years, male sex, typical angina, HT, dyslipidemia and smoking
were significantly greater as compared to those with normal coronaries.ology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Jayanagar, 9th Block,
088694975.
com, medashish@gmail.com (A. Agarwal).
2013, Cardiological Society of India. All rights reserved.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 5 2e5 6 53Conclusion: The overall prevalence of CAD among patients undergoing non-coronary car-
diac surgery is 8.7%. Coronary artery disease is relatively uncommon in patients with
rheumatic VHD (4.9%), while its prevalence is highest in DAVD (23.4%).
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Many patients with valvular and non-valvular heart disease
have concomitant coronary artery disease (CAD), but there
are only limited data regarding optimal strategies for diag-
nosis and treatment of CAD in such patients. The decision
regarding strategies for diagnosis of CAD has been driven by
data from smaller published series of patients undergoing
surgical treatment of valvular heart disease (VHD). The un-
favorable impact of untreated CAD on perioperative and long
term postoperative outcome makes preoperative identifica-
tion of CAD mandatory even in asymptomatic patients.1,2
This anticipated risk forms the basis of American College of
Cardiology/American Heart Association (ACC/AHA) guide-
lines for coronary angiography (CAG) in VHD,3 which states
that CAG should be performed before valve surgery in men
aged 35 years or older, premenopausal women aged 35 years
or older who have coronary risk factors, and postmenopausal
women.
The guidelines address patients with VHD. However, there
are no guidelines regarding the evaluation of CAD in patients
undergoing cardiac surgery for non-valvular etiologies. In
India, CAG is usually performed routinely in rheumatic heart
disease (RHD) patients prior to valve replacement surgery if
there are symptoms of CAD or if the patient is more than 40
years of age. The present study aims to identify the prevalence
of CAD among patients with valvular as well as non-valvular
cardiac pathologies who are scheduled for surgery other
than coronary artery bypass surgery (CABG).2. Methods
This study includes Indian patients with different cardiac
valvular and non-valvular etiologies admitted in department
of cardiothoracic surgery in Sri Jayadeva Institute of Cardio-
vascular Sciences and Research, Bengaluru between October
2011 and January 2013. 300 patients, with primary cardiac
lesion (valvular and non-valvular), referred with indications
for heart surgery, were selected for the study and data was
prospectively collected. All patients with age40 years and an
indication for open heart surgery underwent preoperative
coronary angiogram and were included in the study.
Valvular cases included RHD, mitral valve prolapse (MVP),
degenerative aortic valve disease (DAVD) and bicuspid aortic
valve (BAV). Non-valvular cases included atrial myxoma,
constrictive pericarditis, atrial septal defect and aortic aneu-
rysm. Patients with known case of CAD, prior CABG or
percutaneous coronary intervention or age <40 years were
excluded from the study.Detailed assessment of symptoms such as chest pain,
dyspnea, syncope, and fatigue and of risk factors like hyper-
tension (HT; systolic arterial pressure 140 mmHg or diastolic
arterial pressure 90 mmHg or use of anti-hypertensive
medication), diabetes mellitus (DM; fasting glucose 126 mg/
dl, post-prandial glucose 200 mg/dl or on medications for
DM), smoking, dyslipidemia (total cholesterol 200 mg/dl,
triglycerides 150 mg/dl, and/or LDL 130 mg/dl), overweight
or obesity, family history of cardiovascular disease was done
in all patients. Etiology of cardiac disease was evaluated by
transthoracic and if required, transesophageal echocardio-
gram with two dimensional and color flow imaging. All
selected patients underwent CAG with informed written
consent prior to surgery. Angiographic data was collected
including the presence and absence of significant coronary
artery stenosis (defined as 50% luminal narrowing) and
number of coronaries involved.2.1. Statistical analysis
The data was entered and managed on an Excel spreadsheet,
and analyzed systematically using SPSS 16 statistical software
(SPSS Inc., Chicago, USA). All data were presented as fre-
quency distribution and simple percentages. Descriptive sta-
tistics were presented in the form of mean  SD for all
continuous variables. Categorical variables were expressed as
percentages and analyzed using the chi-square test. A p-value
<0.05 was considered to be statistically significant.3. Results
A total of 300 patients were included in the study. Table 1
shows the baseline demographic and clinical characteristics
of the study cohort. The mean age of the patients was
51.5  9.02 years and mean BMI was 21.26  4.2. 178 (59.3%)
patients were males and 122 (40.7%) patients were females.
The overall prevalence of major risk factors, DM, HT, dyslipi-
demia and smoking was 10.3%, 10.7%, 45% and 31.7% respec-
tively. Out of 300 patients, 270 (90%) patients had VHD and 30
(10%) patients had non-valvular heart disease. Majority (161
patients, 53.7%) of patients of VHD had rheumatic etiology
while DAVD (60 patients, 20%) was the second most common
etiology.
Baseline characteristics were also defined in the individual
diagnosis group (Table 2). Patients with DAVD were signifi-
cantly older (mean age 61.7  7.04 years, p < 0.001) and more
males (42 patients, 70%, p < 0.05) than patients in other
groups. Prevalence of DM, HT, dyslipidemia, smoking and
family history of cardiovascular disease (CVD) was not
significantly different between all the groups (p ¼ NS).
Table 1 e Baseline characteristics of patients.
Characteristics
Age, mean (SD) 51.5 (9.02)
BMI, mean (SD) 21.26 (4.2)
Number Percentage
Males 178 59.3%
Females 122 40.7%
Atypical angina 61 20.3%
Typical angina 87 29.0%
No chest pain 152 50.7%
Overweight or obese 56 18.7%
Diabetes 31 10.3%
Hypertension 32 10.7%
Dyslipidemia 135 45.0%
Smoking 95 31.7%
Family history of CAD 14 4.7%
Valvular (n ¼ 270) 270 90.0%
 RHD 161 53.7%
 MVP 17 5.7%
 BAV 32 10.7%
 Degenerative AV disease 60 20.0%
Non-valvular (n ¼ 30) 30 10.0%
CAD 26 8.7%
CAD, coronary artery disease; RHD, rheumatic heart disease; MVP,
mitral valve prolapse; BAV, bicuspid aortic valve; SD, standard
deviation.
Table 3 e Prevalence and severity of CAD in relation to
different etiologies*.
Lesion Patients with
CAD (%)
SVD
(%)
DVD
(%)
TVD
(%)
LMD
Valvular
(n[ 270)
25 (9.3) 20 (80) 3 (12) 1 (4) 1 (4)
RHD (n ¼ 161) 8 (4.9) 7 (4.3) 0 0 1 (0.6)
MVP (n ¼ 17) 1 (5.9) 1 (5.9) 0 0 0
DAVD (n ¼ 60) 14 (23.4) 10 (16.7) 3 (5) 1 (1.7) 0
BAV (n ¼ 32) 2 (6.2) 2 (6.2) 0 0 0
Non-valvular
(n[ 30)
1 (3.3) 0 0 1 (3.3) 0
*p value <0.05 for comparison between valvular and non-valvular
group and DAVD vs other valvular group. CAD, coronary artery
disease; RHD, rheumatic heart disease; MVP, mitral valve prolapse;
BAV, bicuspid aortic valve; SVD, single vessel disease; DVD, double
vessel disease; TVD, triple vessel disease; LMD, left main disease.
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DAVD group (63.3%, p < 0.05).
Out of 300 patients, 26 (8.7%) patients were found to have
significant CAD (Table 3). CAD was significantly more com-
mon in VHD patients (25 patients, 9.3%) as compared to non-
valvular etiologies (1 patient, 3.3%, p < 0.05). In the valvular
group, DAVD patients had maximum prevalence of CAD (14
patients, 23.4%, p < 0.05). There was no significant difference
in the prevalence of CAD in patients with RHD (4.9%), MVP
(5.9%), BAV (6.2%) and non-valvular etiologies (3.3%). Triple
vessel disease (TVD) was found in only one patient with infra-
renal aortic aneurysm. The patient was 72 years old, smokerTable 2 e Characteristics of patients with valvular and non-va
Variable Valvular (n
RHD (n ¼ 161) MVP (n ¼ 17)
Mean age (SD) 48.96 (7.27) 51.94 (7.6)
Sex Males (%) 85 (52.8) 11 (64.7)
Females (%) 76 (47.2) 6 (35.3)
Mean BMI (SD) 20.8 (4.5) 20.8 (3.4)
Diabetes (%) 15 (9.3) 1 (5.9)
Hypertension (%) 11 (6.8) 3 (17.6)
Dyslipidemia (%) 70 (43.5) 9 (52.9)
Smoking (%) 45 (28) 5 (29.4)
Family history of CAD (%) 6 (3.7) 2 (11.8)
Chest
pain
Absent (%) 100 (62.1) 6 (35.3)
Atypical (%) 29 (18) 10 (58.8)
Typical (%) 32 (19.9) 1 (5.9)
CAD, coronary artery disease; RHD, rheumatic heart disease; MVP, mitral
standard deviation.and had typical angina on exertion. Only one patient of RHD
with severe AR had ostial left main artery 80% stenosis. On
further classifying the valvular group in rheumatic and non-
rheumatic etiologies, CAD was found in 8 (4.9%) patients and
17 (15.6%, p < 0.05) patients respectively. Majority of the pa-
tients had single vessel disease.
The frequency of the disease was higher in males as
compared to females. In the group with CAD, the presence of
variables such as age >60 years, male sex, typical angina, HT,
dyslipidemia and smoking was significantly greater as
compared to those with normal coronaries (Table 4). There
was no significant difference between the group regarding
BMI, DM and family history of CAD. On subgroup analysis, in
all patients with AS irrespective of etiology (120 patients), CAD
was significantly more in patients having typical angina in
comparison to patients without angina. 14 out of 61 patients
(22.9%) with typical angina had CAD while 3 out of 59 patients
(5.1%) without angina had CAD. All patients less than 50 years
of age had 2 major coronary risk factors.lvular heart disease.
¼ 270) Non-valvular
(n ¼ 30)
p value
DAVD (n ¼ 60) BAV (n ¼ 32)
61.7 (7.04) 47.84 (7.54) 48.37 (8.74) <0.001
42 (70) 24 (75) 16 (53.3) <0.05
18 (30) 8 (25) 14 (46.7)
22.6 (3.6) 21.18 (4.1) 21.42 (3.28) 0.080
8 (13.3) 5 (15.6) 2 (6.7) 0.640
11 (18.3) 5 (15.6) 2 (6.7) 0.078
27 (45) 18 (56.2) 11 (36.7) 0.548
25 (41.7) 14 (43.8) 6 (20) 0.096
2 (3.3) 2 (6.2) 2 (6.7) 0.569
17 (28.3) 12 (37.5) 17 (56.7) <0.05
5 (8.3) 7 (21.9) 10 (33.3)
38 (63.3) 13 (40.6) 3 (10)
valve prolapse; BAV, bicuspid aortic valve; BMI, body mass index; SD,
Table 4 e Clinical characteristics of patients with and
without CAD.
With CAD
(n ¼ 26)
Without
CAD
(n ¼ 274)
p value
Variables n % n %
Age <50 years 7 26.9 138 50.4 0.009
Age 50e60 years 7 26.9 79 28.8
Age >60 years 12 46.2 57 20.8
Males 19 73.1 159 58 <0.05
Females 7 26.9 115 42
Typical chest
pain
21 80.8 66 24.1 <0.001
Atypical chest
pain
2 7.7 59 21.5
No chest pain 3 11.5 149 54.4
BMI <25 22 84.6 222 81 0.653
BMI 25 4 15.4 52 19
Diabetes 3 11.5 28 10.2 0.833
Hypertension 11 42.3 21 7.6 <0.001
Dyslipidemia 22 84.6 113 41.2 <0.001
Smokers 16 61.5 79 28.8 0.001
Family history
of CAD
1 3.8 13 4.7 0.836
Valvular 25 96.1 245 89.4 <0.05
 RHD 8 30.8 153 55.8
 MVP 1 3.8 16 5.8
 DAVD 14 53.8 46 16.8
 BAV 2 7.7 30 10.9
Non-valvular 1 3.8 29 10.6
CAD, coronary artery disease; RHD, rheumatic heart disease; MVP,
mitral valve prolapse; BAV, bicuspid aortic valve; BMI, body mass
index.
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Guidelines for CAG in patients with VHD are primarily based
on studies wherein majority of the patients had degenerative
etiology for VHD.3 The overall prevalence of CAD in patients
undergoing valve replacement has been shown to vary widely
from 9% to 41%.4e9 It must be kept in mind that majority of
these patients are elderly, have degenerative valve disease
and havemultiple coronary risk factors. However, in India and
other developing countries where themajor etiology of VHD is
rheumatic, the prevalence of coexistent CAD is much lower as
compared to western patients.10e12
In the present study, the overall prevalence of CAD in all
groups was 8.7%, which is much lower than in the western
population. It has been postulated that rheumatic fever may
lead to arteritis in intramyocardial coronaries. However, it has
not been proven and the actual prevalence of CAD in RHD
patients is notmore than in general population. In the present
study, CAD was found in 4.9% patients of RHD patients. The
prevalence is much lower as compared to previous studies.
Marchant et al13 analyzed CAG of 100 patients with rheumatic
valvular disease and reported the prevalence of significant
CAD to be 14%. In that study coronary angiography was per-
formed in patients over the age of 50 years, those having
angina or ECG signs of ischemia, which can explain the higher
prevalence. Shaikh et al14 reviewed medical records of 144patients and found CAD in 25% patients of RHD. This may be
related to very high frequency of DM, HT and dyslipidemia in
the study population. Two studies from India by Jose et al10
and Narang et al15 have reported prevalence of CAD to be
12.2% and 11% respectively in patients with RHD undergoing
valve replacement. However, the baseline characteristics of
patients with regards to CAD risk factors were not mentioned
in study by Narang et al.15 Also the symptoms were not
assessed in the study.
Kruczan et al,12 in his study of 294 patients with rheumatic
and non-rheumatic VHD reported that patients with rheu-
matic VHD had lower prevalence of CAD (4%) when compared
to those with non-rheumatic VHD (33.61%). The prevalence of
CAD (4%) in this study is similar to that of our study (4.9%) in
patients with rheumatic VHD. The prevalence of CAD in non-
rheumatic etiology was still higher (33.61%) as compared to
the present study (15.6%). This higher prevalence has been
attributed to more frequency of male sex, older age andmajor
coronary risk factors in non-rheumatic group. The prevalence
of CAD in patients of DAVD in this study was 23.4%, which is
higher as compared to other groups. This is related to the fact
that this population was characterized by predominance of
male sex and older age, in opposition of what was observed in
other groups. Typical angina was also significantly higher in
the DAVD group. In isolated degenerative aortic stenosis, the
prevalence of CAD is reported to be as high as 37% in patients
aged between 40 and 59 and 64% in those aged between 60 and
82 years,16 which was also much higher as compared to our
study (23.4%). It is likely to be related to the genetic, racial and
environmental factors. Also, most patients in our study were
from a lower socioeconomic status, where the prevalence of
CAD would likely to be lower.
Patients with non-valvular heart diseases are not enrolled
in previous studies. In present study, out of 30 patients with
non-valvular etiologies, only one patient was found to have
CAD (TVD). However, the patientwas 72 years old, smoker and
had typical angina on exertion. Hence, it can be concluded
that preoperative angiography in this subset of patients can be
restricted to those patients who are older, symptomatic and/
or have other major risk factors for CAD. However, larger
studies, focusing on this issue, are required to further
enlighten the exact prevalence and need for CAG in these
patients.
The demographic and clinical characteristics that charac-
terized the patients from CAD group were of age >50 years,
male sex, typical chest pain, hypertension, dyslipidemia,
smoking and DAVD. Of note, CAD was present in only 4.8% of
patients <50 years of age as compared to 12.2% of patients
with50 years of age. In patients with age<50 years, CADwas
found only in patients with 2 major coronary risk factors. It
can be concluded that in this subset of patients, CAG can be
considered only in the presence of multiple coronary risk
factors or symptoms suggestive of CAD, or if there is high
clinical likelihood of CAD.5. Study limitations
Although this study included relatively large number of pa-
tients with valvular heart disease, the number of patients in
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 5 2e5 656the non-valvular group was low. A large study specifically
involving this subset of patients is required to give more
realistic prevalence in these patients.6. Conclusion
The study provides data on prevalence of CAD in Indian pa-
tients with valvular and non-valvular heart diseases under-
going surgical treatment. The overall prevalence of significant
CAD in this group of patients was 8.7%. The prevalence of CAD
in patients with rheumatic valve disease was low whereas it
was highest in those with DAVD. In patients under the age of
50 years, significant CAD was low and was present only in
those with more than 2 coronary risk factors.Conflicts of interest
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